In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I

Kara Manning, Muhsen Al-Dhalimy, Milton Finegold, Markus Grompe

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Hereditary tyrosinemia type I and alkaptonuria are disorders of tyrosine catabolism caused by deficiency of fumarylacetoacetate hydrolase (FAH) and homogentisic acid dioxygenase (HGD), respectively. Tyrosinemia is a severe childhood disease that affects the liver and kidneys, but alkaptonuria is a more benign adult disorder in comparison. Because HGD is upstream of FAH in the tyrosine pathway, mice doubly mutant in both enzymes were found to be protected from the liver and renal damage of tyrosinemia as hypothesized. Mice mutant at the tyrosinemic locus but heterozygous for alkaptonuria spontaneously developed clonal nodules of functionally normal hepatocytes that were able to rescue the livers of some mice with this genotype. This phenotypic rescue was a result of an inactivating mutation of the wild-type homogentisic acid dioxygenase gene, thus presenting an example of an in vivo suppressor mutation in a mammalian model.

Original languageEnglish (US)
Pages (from-to)11928-11933
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number21
DOIs
StatePublished - Oct 12 1999

Fingerprint

Homogentisic Acid
Alkaptonuria
Tyrosinemias
Genetic Suppression
Dioxygenases
Tyrosine
Liver
Kidney Diseases
Liver Diseases
Hepatocytes
Genotype
Kidney
Mutation
Enzymes
Genes
fumarylacetoacetase

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I. / Manning, Kara; Al-Dhalimy, Muhsen; Finegold, Milton; Grompe, Markus.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 21, 12.10.1999, p. 11928-11933.

Research output: Contribution to journalArticle

@article{f4883a7031734c6896a2d47c87ff9686,
title = "In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I",
abstract = "Hereditary tyrosinemia type I and alkaptonuria are disorders of tyrosine catabolism caused by deficiency of fumarylacetoacetate hydrolase (FAH) and homogentisic acid dioxygenase (HGD), respectively. Tyrosinemia is a severe childhood disease that affects the liver and kidneys, but alkaptonuria is a more benign adult disorder in comparison. Because HGD is upstream of FAH in the tyrosine pathway, mice doubly mutant in both enzymes were found to be protected from the liver and renal damage of tyrosinemia as hypothesized. Mice mutant at the tyrosinemic locus but heterozygous for alkaptonuria spontaneously developed clonal nodules of functionally normal hepatocytes that were able to rescue the livers of some mice with this genotype. This phenotypic rescue was a result of an inactivating mutation of the wild-type homogentisic acid dioxygenase gene, thus presenting an example of an in vivo suppressor mutation in a mammalian model.",
author = "Kara Manning and Muhsen Al-Dhalimy and Milton Finegold and Markus Grompe",
year = "1999",
month = "10",
day = "12",
doi = "10.1073/pnas.96.21.11928",
language = "English (US)",
volume = "96",
pages = "11928--11933",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I

AU - Manning, Kara

AU - Al-Dhalimy, Muhsen

AU - Finegold, Milton

AU - Grompe, Markus

PY - 1999/10/12

Y1 - 1999/10/12

N2 - Hereditary tyrosinemia type I and alkaptonuria are disorders of tyrosine catabolism caused by deficiency of fumarylacetoacetate hydrolase (FAH) and homogentisic acid dioxygenase (HGD), respectively. Tyrosinemia is a severe childhood disease that affects the liver and kidneys, but alkaptonuria is a more benign adult disorder in comparison. Because HGD is upstream of FAH in the tyrosine pathway, mice doubly mutant in both enzymes were found to be protected from the liver and renal damage of tyrosinemia as hypothesized. Mice mutant at the tyrosinemic locus but heterozygous for alkaptonuria spontaneously developed clonal nodules of functionally normal hepatocytes that were able to rescue the livers of some mice with this genotype. This phenotypic rescue was a result of an inactivating mutation of the wild-type homogentisic acid dioxygenase gene, thus presenting an example of an in vivo suppressor mutation in a mammalian model.

AB - Hereditary tyrosinemia type I and alkaptonuria are disorders of tyrosine catabolism caused by deficiency of fumarylacetoacetate hydrolase (FAH) and homogentisic acid dioxygenase (HGD), respectively. Tyrosinemia is a severe childhood disease that affects the liver and kidneys, but alkaptonuria is a more benign adult disorder in comparison. Because HGD is upstream of FAH in the tyrosine pathway, mice doubly mutant in both enzymes were found to be protected from the liver and renal damage of tyrosinemia as hypothesized. Mice mutant at the tyrosinemic locus but heterozygous for alkaptonuria spontaneously developed clonal nodules of functionally normal hepatocytes that were able to rescue the livers of some mice with this genotype. This phenotypic rescue was a result of an inactivating mutation of the wild-type homogentisic acid dioxygenase gene, thus presenting an example of an in vivo suppressor mutation in a mammalian model.

UR - http://www.scopus.com/inward/record.url?scp=0032692849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032692849&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.21.11928

DO - 10.1073/pnas.96.21.11928

M3 - Article

C2 - 10518553

AN - SCOPUS:0032692849

VL - 96

SP - 11928

EP - 11933

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -